According to SDi’s recent publication, The 2019 Market for Live Cell Imaging, the total market for live cell imaging instruments, assays, and labeling reagents is projected to reach $1.9 billion in five years with a CAGR of 7.3%. Among the factors driving this high growth is the increasing adoption of advanced microscopy techniques for live […]
Strategic Directions International (SDi), part of Science and Medicine Group, announced the release of their 2018 Bioprocessing Market Analysis and Perspectives report. The report details market data and commentary for five key bioprocessing technologies with segmentation and growth by product type, region, and end market; vendor share data and commentary are also provided. In addition, […]
In this article we discuss some of the product categories covered by the SDi Global Assessment Report 2018: The Laboratory Analytical & Life Science Instrumentation Industry. The SDi Global Report is comprised of ten major sections, each devoted to a major class of instrumentation. Here’s what manufacturers can expect in 2018. Chromatography: Mobile and High […]
Current indications are that India will have the strongest regional market for life science and analytical instrumentation and lab products in 2017, with growth forecast at 7.5%, followed closely by China at 6.8%. Both countries continue to develop rapidly with private and public investments, but the Chinese market has grown to such a size that […]
Strategic Directions International (SDi), a division of BioInformatics LLC, today announced the release of the 2017 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry. The 800+ page report details the size, growth and depicts market share for 82 separate categories of laboratory instruments and consumables. In addition projections are made on the […]
Cell-based assays are an essential component to any life scientist’s tool kit. Whether in academic or industry-based research, the versatility of cell-based assays has allowed for them to be employed in a wide range of applications. These assays allow scientists to analyze complex cellular functions, to probe the relationship between cellular dysfunction and disease, to […]
Establishing a regulatory pathway for pharmaceutical companies in the U.S. to manufacture biosimilar drugs presents a much anticipated new market opportunity for life science analytical instrument suppliers.
If the goal is to reinforce product differentiation and brand recognition, advertising—both in print and online—is the way to go.
Scientists evaluate lab products—constantly—and adopt the ones that improve their work. That is, provided their budget doesn’t get in the way.
While it’s no surprise that labs are gaining more control over the buying process, the real question is how to deploy a sales force to build relationships, act as intermediary between labs and suppliers and, well, increase sales.
June 12, 2020 1:50 pm
May 27, 2020 1:33 pm
May 8, 2020 4:23 pm
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.